Cancer risk in carriers of TP53 germline variants grouped into different functional categories.
Müntnich LJ, Dutzmann CM, Großhennig A, Härter V, Keymling M, Mastronuzzi A, Montellier E, Nees J, Palmaers NE, Penkert J, Pfister SM, Ripperger T, Schott S, Silchmüller F, Hainaut P, Kratz CP.
Müntnich LJ, et al. Among authors: grosshennig a.
JNCI Cancer Spectr. 2025 Jan 28:pkaf008. doi: 10.1093/jncics/pkaf008. Online ahead of print.
JNCI Cancer Spectr. 2025.
PMID: 39873732